Ciarán Fitzpatrick, EditorBack to top
Ciaràn is a Senior Editor with the BMC Series. He obtained his BSc in Neuroscience from University College Dublin, MSc & PhD in Pharmaceutical Sciences from University of Copenhagen, Denmark. He has authored 15 peer-reviewed articles developing behavioral tests to study psychiatric illnesses in rodents and humans. Having most enjoyed the publishing process while researching, Ciaràn relocated to London to pursue an Editorial career at BMC Series. He is committed to promoting open access, robust, and reproducible science at BMC Musculoskeletal Disorders, BMC Rheumatology, and BMC Sports Science, Medicine & Rehabilitation.
Assistant Editor: Sarah Gray.
Alessia AlunnoBack to top
Alessia undertook her medical degree, specialty training in Rheumatology and PhD in medical biotechnologies at the University of Perugia, Italy. During her training, she also completed a research fellowship at the Centre for Experimental Medicine and Rheumatology, Queen Mary University of London, United Kingdom. Her research activity mainly focuses on the interplay of T and B lymphocyte subsets and on the identification of novel autoantibodies in Sjögren’s syndrome and rheumatoid arthritis. Over the last decade Alessia gained extensive experience on the immunopathogenesis of rheumatic diseases and co-authored over 80 articles in international peer-reviewed journals. Since 2016 Alessia is assistant professor of rheumatology working at the Rheumatology Unit, University of Perugia, Italy. In 2014 she joined the Editorial Board of BMC Musculoskeletal Disorders as an Associate Editor and became a Senior Editorial Board Member of BMC Rheumatology in 2017.
Chang-Hee SuhBack to top
Chang-Hee is a professor and director of the Rheumatology, Ajou University School of Medicine since March 2010 and director of Clinical Trial Center, Ajou University Hospital since March 2017. He obtained his MS in Medicine and PhD in Rheumatology from Yonsei University, Seoul, Korea. He worked as a postdoctoral Fellow in the Department of Rheumatology, University of Pennsylvania. He has published more than 290 peer-reviewed articles with more than 4,000 citations. His research interest is the pathogenesis of autoimmune disease, diagnostic and disease activity markers in lupus, and development of new disease-specific treatment in autoimmune diseases.
Antonio LaCavaBack to top
Antonio La Cava, M.D., Ph.D., is Professor of Medicine at the David Geffen School of Medicine of the University of California Los Angeles (UCLA), where he directs the UCLA Center of Excellence for the Federation of Clinical Immunology Societies. He serves in the editorial board of many scientific journals and is a member of grant review panels at the NIH and many international scientific Institutions. His research focuses on the mechanisms of immune tolerance and the pathogenesis of autoimmune diseases and is supported by grants from the National Institutes of Health (NIH) and by other Foundations. His major interest is the development of effective translational strategies of immune-based intervention, with an emphasis on the characterization of unique properties of regulatory T lymphocytes in animal models of autoimmune disease.
Annual Journal Metrics
4.000 - CiteScore
0.980 - SNIP (Source Normalized Impact per Paper)
0.886 - SJR (SCImago Journal Rank)
43 days to first decision for all manuscripts (Median)
51 days to first decision for reviewed manuscripts only (Median)
260,140 downloads (2022)
265 Altmetric mentions (2021)
Transparency and Openess
TOP Factor Score - 8
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication